See more : Bersama Mencapai Puncak Tbk. (BAIK.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Verano Holdings Corp. (VRNO.NE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Verano Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- ATI Physical Therapy, Inc. (ATIP-WT) Income Statement Analysis – Financial Results
- Aton Resources Inc. (ANLBF) Income Statement Analysis – Financial Results
- TaiRx, Inc. (6580.TWO) Income Statement Analysis – Financial Results
- HeidelbergCement India Limited (HEIDELBERG.BO) Income Statement Analysis – Financial Results
- H-Farm S.p.A. (FARM.MI) Income Statement Analysis – Financial Results
Verano Holdings Corp. (VRNO.NE)
About Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers artisanal cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 938.45M | 1.14B | 925.07M | 306.53M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 463.25M | 610.07M | 519.83M | 149.51M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 475.21M | 534.79M | 405.23M | 157.02M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 50.64% | 46.71% | 43.81% | 51.22% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 179.54M | 0.00 | 57.96K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 8.64M | 0.00 | 17.75K | 0.00 | 0.00 |
| SG&A | 331.93M | 448.23M | 329.90M | 33.21M | 75.71K | 136.93K | 74.48K |
| Other Expenses | 58.49M | 31.64M | 9.63M | -701.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 390.42M | 448.23M | 329.90M | 33.21M | 75.71K | 136.93K | 74.48K |
| Cost & Expenses | 853.67M | 1.06B | 849.73M | 182.72M | 75.71K | 136.93K | 74.48K |
| Interest Income | 0.00 | 0.00 | 0.00 | -3.02M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 59.79M | 49.43M | 24.27M | 7.44M | 0.00 | 3.54K | 10.76K |
| Depreciation & Amortization | 151.63M | 195.70M | 120.66M | 10.55M | 0.00 | 0.00 | 0.00 |
| EBITDA | 239.22M | 47.32M | 212.51M | 134.36M | -75.71K | -136.93K | -1.27M |
| EBITDA Ratio | 25.49% | 24.65% | 21.19% | 43.83% | 0.00% | 0.00% | 0.00% |
| Operating Income | 84.78M | 86.56M | 75.34M | 123.81M | -75.71K | -136.93K | -74.48K |
| Operating Income Ratio | 9.03% | 7.56% | 8.14% | 40.39% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -56.99M | -2.27M | -13.92M | -16.83M | -7.37K | -3.55K | -1.20M |
| Income Before Tax | 27.80M | -212.73M | 61.42M | 106.98M | -83.08K | -140.48K | -1.28M |
| Income Before Tax Ratio | 2.96% | -18.58% | 6.64% | 34.90% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 145.15M | 137.31M | 130.37M | 56.73M | -4.25K | -12.04K | 0.00 |
| Net Income | -117.35M | -350.41M | -72.10M | 51.51M | -78.83K | -128.44K | -1.28M |
| Net Income Ratio | -12.50% | -30.61% | -7.79% | 16.80% | 0.00% | 0.00% | 0.00% |
| EPS | -0.34 | -1.03 | -0.22 | 0.18 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.34 | -1.03 | -0.22 | 0.18 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 342.77M | 339.98M | 324.31M | 290.09M | 290.09M | 16.56B | 16.56B |
| Weighted Avg Shares Out (Dil) | 342.77M | 339.98M | 324.31M | 290.09M | 290.09M | 16.56B | 16.56B |
Source: https://incomestatements.info
Category: Stock Reports